Here are relevant reports on : induced-pluripotent-stem-cells-market
-
Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue & Banking), End User, Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028
The global stem cell manufacturing market, valued at US$12.0 billion in 2022, stood at US$12.7 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$21.8 billion by the end of the period. The major factors driving the growth of this market are technological advancements in stem cell manufacturing and the increasing prevalence of genetic disorders, both of which are expected to propel market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) & Region - Global Forecast to 2029
The global autologous stem cell & non-stem cell therapies market, valued at US$3.9 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2029, culminating in a forecasted valuation of US$22.2 billion by the end of the period. The major factors driving the growth of this market are the rising regulatory approvals for autologous CAR T cell therapies, increasing R&D investments in autologous therapeutics, and growing demand for personalized medicines.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Single-use Bioreactors Market by Product (Systems, Bags, Assemblies), Type (Stirred Tank, Bubble-Column, Wave induced), Molecule (mAbs, Vaccines), Cell Type (Mammalian, Bacterial, Yeast), Application (R&D, Bioproduction) - Global Forecast to 2029
The global single-use bioreactors market, valued at US$4.1 billion in 2023, stood at US$4.4 billion in 2024 and is projected to advance at a resilient CAGR of 15.4% from 2024 to 2029, culminating in a forecasted valuation of US$9.1 billion by the end of the period. Advantages over conventional bioreactors, lower capital investment, reduced water and energy usage, the expanding biologics and biosimilars markets, and increased adoption among CDMOs, CMOs, and SMEs are some of the factors driving market growth.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Ultra-High Strength Steel Market by Type (Dual Phase, Complex Phase, Multiphase, Martensitic, Transformation-Induced Plasticity), End-Use Industry (Automotive and Aerospace & Defense), and Region - Global Forecast to 2022
The ultra-high strength steel market is estimated to be USD 7.96 Billion in 2017 and is projected to reach USD 11.35 Billion by 2022, at a CAGR of 7.35% from 2017 to 2022. The United States Steel Corporation (US), ArcelorMittal (Luxembourg), Schuler Group (Germany), SAIL (India), China Baowu Steel Group Corp. (China), POSCO (South Korea), Tata Steel (India), JSW Steel (India), Voestalpine Group (Austria), Nippon Steel & Sumitomo Metal Corporation (Japan), Kobe Steel (Japan), China Steel Corporation (Taiwan), JFE Steel (Japan), Essar Steel (Mumbai), Novolipetsk Steel (Russia), Angang Steel Company Limited (China), Nucor Corporation (US), Gerdau S.A. (Brazil), AK Steel Holding Corporation (US), Hyundai Steel Co., Ltd. (South Korea), Usiminas (Brazil), Hebei Puyang Iron and Steel Co., Ltd. (China), and Shougang Corporation (China) are key players operating in the ultra-high strength steel market.
- Published: November 2017
- Price: $ 4950
- TOC Available:
-
Electromagnetic Weapons Market by Product (Lethal Weapons, Non-lethal Weapons), Application (Homeland Security, Military), Platform (Land, Naval, Airborne), Technology (Particle Beam Weapons, Laser-induced Plasma Channel), and Region 2026
According to MarketsandMarkets, the electromagnetic weapons market is projected to reach USD 1,282 million by 2026, at a CAGR of 20.3% during the forecasting period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Lockheed Martin Corporation (US), Northrop Grumman Corporation (US), Thales Group (France), BAE Systems (UK), Raytheon Technologies (US), Elbit Systems (Israel) and L3Harris Technologies (US).
- Published: September 2021
- Price: $ 4950
- TOC Available:
-
Polymer/Organic Solar Cells Market, Global Forecast & Analysis (2011-2016)
Polymer solar cells are lightweight as compare to silicon based devices. These cells are used in applications like autonomous sensors. Impact on environment is also very lower as compare to silicon based devices. It can be used in application like low energy calculators, battery chargers, charging back up and electrical feeders. polymer based solar cells are (one-tenth) cheaper from the price of normal solar cells.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), End User (Hospitals) & Region - Global Forecasts to 2023
The cell surface markers market is projected to reach USD 769 million by 2023, at a CAGR of 8.1%. Factors such as the increasing funding for life sciences research, high global prevalence of cancer, and growth in stem cell and neurobiology research are expected to drive the growth of this market in the coming years.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Neuroblastoma Cancer Market by Diagnostics (MIBG Scan, Imaging, Urine Analysis, Biopsy), Treatment (Surgery, Chemotherapy, Radiation therapy, Stem Cell Transplant, Immunotherapy), Staging, Pipeline, Regulatory, Reimbursement - Global Forecast to 2021
Neuroblastoma is a rare extracranial solid tumor cancer that develops from immature nerve cells found in several areas of the body. It is the most common extracranial solid tumor in childhood.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023
The global cell harvesting market is expected to reach USD 324.5 Million by 2023, at a CAGR of 8.7%. Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030
The global exosome research market, valued at US$189.4 million in 2024, stood at US$214.4 million in 2025 and is projected to advance at a resilient CAGR of 17.5% from 2025 to 2030, culminating in a forecasted valuation of US$480.6 million by the end of the period. The growth of the Asia Pacific exosome research market is primarily due to the growing biomedical industry, increasing life science research, and rising investments by pharmaceutical & biotechnology companies in this region.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
